US Stock MarketDetailed Quotes

MMSI Merit Medical Systems

Watchlist
  • 104.980
  • +0.300+0.29%
Trading Mar 25 14:25 ET
6.18BMarket Cap51.71P/E (TTM)

Merit Medical Systems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
7.89%1.36B
9.44%355.16M
7.81%339.85M
5.61%338M
8.72%323.51M
9.24%1.26B
10.60%324.52M
9.77%315.23M
8.50%320.06M
8.04%297.57M
Operating revenue
7.89%1.36B
9.44%355.16M
7.81%339.85M
5.61%338M
8.72%323.51M
9.24%1.26B
10.60%324.52M
9.77%315.23M
8.50%320.06M
8.04%297.57M
Cost of revenue
5.89%713.18M
4.71%182.18M
5.36%182.31M
5.76%176.9M
7.91%171.79M
6.59%673.49M
9.52%173.99M
9.10%173.03M
4.61%167.27M
3.04%159.2M
Gross profit
10.18%643.33M
14.92%172.98M
10.78%157.54M
5.44%161.1M
9.65%151.72M
12.48%583.87M
11.87%150.53M
10.60%142.2M
13.12%152.78M
14.44%138.36M
Operating expense
6.75%487.2M
16.08%136.27M
12.84%120.17M
-5.13%114.85M
3.99%115.91M
9.18%456.4M
13.22%117.39M
-2.29%106.5M
16.45%121.06M
9.92%111.46M
Selling and administrative expenses
6.97%399.73M
16.00%111.07M
14.73%99.64M
-6.28%94.59M
4.75%94.43M
9.09%373.68M
15.03%95.75M
-3.26%86.85M
18.06%100.93M
7.30%90.14M
Research and development costs
5.73%87.47M
16.43%25.19M
4.48%20.53M
0.67%20.26M
0.79%21.48M
9.56%82.73M
5.89%21.64M
2.21%19.65M
9.01%20.13M
22.59%21.31M
Operating profit
22.49%156.14M
10.79%36.72M
4.66%37.36M
45.79%46.25M
33.08%35.81M
26.13%127.47M
7.34%33.14M
82.40%35.7M
1.97%31.73M
37.93%26.9M
Net non-operating interest income expense
61.78%-4.99M
-6.48%-3.25M
81.78%-849K
96.59%-118K
59.04%-770K
-121.27%-13.06M
-50.00%-3.05M
-171.72%-4.66M
-176.44%-3.46M
-109.35%-1.88M
Non-operating interest income
968.00%26.23M
146.54%4.74M
3,575.14%6.65M
3,321.27%7.56M
5,454.20%7.28M
459.45%2.46M
1,463.41%1.92M
56.03%181K
130.21%221K
25.96%131K
Non-operating interest expense
101.27%31.22M
60.60%7.99M
54.95%7.5M
108.56%7.68M
300.10%8.05M
144.69%15.51M
130.52%4.98M
164.39%4.84M
173.15%3.68M
100.70%2.01M
Other net income (expense)
50.34%-1.15M
-123.01%-318K
117.38%142K
91.35%-291K
-244.33%-687K
81.46%-2.32M
4.86%1.38M
-220.39%-817K
63.27%-3.37M
110.73%476K
Special income (charges)
87.43%-443K
-131.92%-151K
81.67%-103K
89.50%-306K
122.46%117K
73.90%-3.52M
203.73%473K
38.58%-562K
62.92%-2.91M
87.80%-521K
-Less：Restructuring and merger&acquisition
-74.00%443K
131.92%151K
-81.67%103K
-72.03%306K
-122.46%-117K
-63.04%1.7M
-419.78%-473K
-38.58%562K
-7.83%1.09M
-79.96%521K
-Less:Impairment of capital assets
--0
----
----
----
----
-87.83%270K
----
----
----
----
-Less:Other special charges
----
----
----
----
----
-76.77%1.55M
--0
----
-76.77%1.55M
----
-Write off
----
----
--0
--0
----
----
----
--0
--270K
----
Other non- operating income (expenses)
-159.25%-711K
-118.37%-167K
196.08%245K
103.33%15K
-180.64%-804K
24.22%1.2M
-48.76%909K
-138.64%-255K
65.39%-451K
707.93%997K
Income before tax
33.82%149.99M
5.33%33.15M
21.29%36.66M
84.11%45.84M
34.70%34.35M
35.65%112.09M
4.35%31.47M
71.70%30.22M
20.28%24.9M
79.94%25.5M
Income tax
67.64%29.64M
35.44%5.2M
87.17%8.21M
117.34%10.12M
27.33%6.11M
117.90%17.68M
218.24%3.84M
88.33%4.39M
-13.84%4.66M
32.29%4.8M
Net income
27.48%120.36M
1.15%27.95M
10.10%28.44M
76.47%35.73M
36.41%28.24M
26.70%94.41M
-17.28%27.63M
69.16%25.83M
32.34%20.25M
96.33%20.7M
Net income continuous Operations
27.48%120.36M
1.15%27.95M
10.10%28.44M
76.47%35.73M
36.41%28.24M
26.70%94.41M
-17.28%27.63M
69.16%25.83M
32.34%20.25M
96.33%20.7M
Minority interest income
Net income attributable to the parent company
27.48%120.36M
1.15%27.95M
10.10%28.44M
76.47%35.73M
36.41%28.24M
26.70%94.41M
-17.28%27.63M
69.16%25.83M
32.34%20.25M
96.33%20.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.48%120.36M
1.15%27.95M
10.10%28.44M
76.47%35.73M
36.41%28.24M
26.70%94.41M
-17.28%27.63M
69.16%25.83M
32.34%20.25M
96.33%20.7M
Basic earnings per share
26.22%2.07
0.00%0.48
8.89%0.49
74.29%0.61
36.11%0.49
25.19%1.64
-17.24%0.48
66.67%0.45
29.63%0.35
89.47%0.36
Diluted earnings per share
25.31%2.03
-4.17%0.46
9.09%0.48
74.29%0.61
33.33%0.48
25.58%1.62
-17.24%0.48
62.96%0.44
29.63%0.35
100.00%0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 7.89%1.36B9.44%355.16M7.81%339.85M5.61%338M8.72%323.51M9.24%1.26B10.60%324.52M9.77%315.23M8.50%320.06M8.04%297.57M
Operating revenue 7.89%1.36B9.44%355.16M7.81%339.85M5.61%338M8.72%323.51M9.24%1.26B10.60%324.52M9.77%315.23M8.50%320.06M8.04%297.57M
Cost of revenue 5.89%713.18M4.71%182.18M5.36%182.31M5.76%176.9M7.91%171.79M6.59%673.49M9.52%173.99M9.10%173.03M4.61%167.27M3.04%159.2M
Gross profit 10.18%643.33M14.92%172.98M10.78%157.54M5.44%161.1M9.65%151.72M12.48%583.87M11.87%150.53M10.60%142.2M13.12%152.78M14.44%138.36M
Operating expense 6.75%487.2M16.08%136.27M12.84%120.17M-5.13%114.85M3.99%115.91M9.18%456.4M13.22%117.39M-2.29%106.5M16.45%121.06M9.92%111.46M
Selling and administrative expenses 6.97%399.73M16.00%111.07M14.73%99.64M-6.28%94.59M4.75%94.43M9.09%373.68M15.03%95.75M-3.26%86.85M18.06%100.93M7.30%90.14M
Research and development costs 5.73%87.47M16.43%25.19M4.48%20.53M0.67%20.26M0.79%21.48M9.56%82.73M5.89%21.64M2.21%19.65M9.01%20.13M22.59%21.31M
Operating profit 22.49%156.14M10.79%36.72M4.66%37.36M45.79%46.25M33.08%35.81M26.13%127.47M7.34%33.14M82.40%35.7M1.97%31.73M37.93%26.9M
Net non-operating interest income expense 61.78%-4.99M-6.48%-3.25M81.78%-849K96.59%-118K59.04%-770K-121.27%-13.06M-50.00%-3.05M-171.72%-4.66M-176.44%-3.46M-109.35%-1.88M
Non-operating interest income 968.00%26.23M146.54%4.74M3,575.14%6.65M3,321.27%7.56M5,454.20%7.28M459.45%2.46M1,463.41%1.92M56.03%181K130.21%221K25.96%131K
Non-operating interest expense 101.27%31.22M60.60%7.99M54.95%7.5M108.56%7.68M300.10%8.05M144.69%15.51M130.52%4.98M164.39%4.84M173.15%3.68M100.70%2.01M
Other net income (expense) 50.34%-1.15M-123.01%-318K117.38%142K91.35%-291K-244.33%-687K81.46%-2.32M4.86%1.38M-220.39%-817K63.27%-3.37M110.73%476K
Special income (charges) 87.43%-443K-131.92%-151K81.67%-103K89.50%-306K122.46%117K73.90%-3.52M203.73%473K38.58%-562K62.92%-2.91M87.80%-521K
-Less：Restructuring and merger&acquisition -74.00%443K131.92%151K-81.67%103K-72.03%306K-122.46%-117K-63.04%1.7M-419.78%-473K-38.58%562K-7.83%1.09M-79.96%521K
-Less:Impairment of capital assets --0-----------------87.83%270K----------------
-Less:Other special charges ---------------------76.77%1.55M--0-----76.77%1.55M----
-Write off ----------0--0--------------0--270K----
Other non- operating income (expenses) -159.25%-711K-118.37%-167K196.08%245K103.33%15K-180.64%-804K24.22%1.2M-48.76%909K-138.64%-255K65.39%-451K707.93%997K
Income before tax 33.82%149.99M5.33%33.15M21.29%36.66M84.11%45.84M34.70%34.35M35.65%112.09M4.35%31.47M71.70%30.22M20.28%24.9M79.94%25.5M
Income tax 67.64%29.64M35.44%5.2M87.17%8.21M117.34%10.12M27.33%6.11M117.90%17.68M218.24%3.84M88.33%4.39M-13.84%4.66M32.29%4.8M
Net income 27.48%120.36M1.15%27.95M10.10%28.44M76.47%35.73M36.41%28.24M26.70%94.41M-17.28%27.63M69.16%25.83M32.34%20.25M96.33%20.7M
Net income continuous Operations 27.48%120.36M1.15%27.95M10.10%28.44M76.47%35.73M36.41%28.24M26.70%94.41M-17.28%27.63M69.16%25.83M32.34%20.25M96.33%20.7M
Minority interest income
Net income attributable to the parent company 27.48%120.36M1.15%27.95M10.10%28.44M76.47%35.73M36.41%28.24M26.70%94.41M-17.28%27.63M69.16%25.83M32.34%20.25M96.33%20.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.48%120.36M1.15%27.95M10.10%28.44M76.47%35.73M36.41%28.24M26.70%94.41M-17.28%27.63M69.16%25.83M32.34%20.25M96.33%20.7M
Basic earnings per share 26.22%2.070.00%0.488.89%0.4974.29%0.6136.11%0.4925.19%1.64-17.24%0.4866.67%0.4529.63%0.3589.47%0.36
Diluted earnings per share 25.31%2.03-4.17%0.469.09%0.4874.29%0.6133.33%0.4825.58%1.62-17.24%0.4862.96%0.4429.63%0.35100.00%0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Wintech Nano
688757
+202.42%
CHANGFU CO.,LTD
871396
+29.97%
DIER CHEMICAL
831304
+27.61%
4
CHENGUANG MEDICAL
430300
+21.92%
5
TLC
873576
+20.34%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025